Ars Pharmaceuticals, Inc.
Clinical trials sponsored by Ars Pharmaceuticals, Inc., explained in plain language.
-
New hives drug shows promise in early trial
Symptom relief Recruiting nowThis study tests a new medication called ARS-2 for people with chronic spontaneous urticaria (long-term hives). It aims to see if ARS-2 can quickly reduce itching and hives during flare-ups. The trial involves 42 adults who will receive either ARS-2 or a placebo during separate f…
Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Nasal spray vs. needle: new study tests easier allergy rescue
Symptom relief Recruiting nowThis study looks at the safety of a nasal spray called neffy compared to a standard epinephrine shot for treating allergic reactions. It involves 600 people aged 4 and older who have an allergic reaction during a food challenge or allergy shot session. The goal is to see if the s…
Phase: PHASE4 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC